Erudio Healtherudio.com
Sponsor
Kartos Therapeutics trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Kartos Therapeutics yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by Kartos Therapeutics: BOREAS, NCT04113616 and POIESIS. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Kartos Therapeutics, Inc.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| BOREAS NCT03662126 · Kartos Therapeutics, Inc. DeepView → | myelofibrosis relapsed or refractory to JAK inhibitor treatment | Phase 2/Phase 3 | Deep | View | |||
| POIESIS NCT06479135 · Kartos Therapeutics, Inc. DeepView → | JAK inhibitor-naïve myelofibrosis with suboptimal response to ruxolitinib | Phase 3 | Deep | View | |||
| NCT04113616 NCT04113616 · Kartos Therapeutics, Inc. FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||